The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
TGN1412: ScrutiniZing preclinical trials of antibody- based medicines
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Later, it was reviewed by Hansen and Leslie[11] that differences of up to 4% existed in the amino-acid sequences of the C”D loop of CD28 receptor in rhesus and cynomolgus with that of humans.”
From TGN1412: From Discovery to Disaster (2010) · cites this paper as [11]
Citations
Cites
Can super-antibody drugs be tamed?
(2006) · Nature · doi:10.1038/440855a · Cited by 47
Cited by
Animal models in translational medicine: Validation and prediction
Denayer, T., Stöhr, T., & Roy, M. V. (2014) · European Journal of Molecular & Clinical Medicine · doi:10.1016/j.nhtm.2014.08.001 · Cited by 448
TGN1412: From Discovery to Disaster
Attarwala, H. (2010) · Journal of Young Pharmacists · doi:10.4103/0975-1483.66810 · Cited by 253
“Later, it was reviewed by Hansen and Leslie[11] that differences of up to 4% existed in the amino-acid sequences of the C′′D loop of CD28 receptor in rhesus and cynomolgus with that of humans.”
Magnetic Fe3O4–graphene composites as targeted drug nanocarriers for pH-activated release
Fan, X., Jiao, G., Zhao, W., Jin, P., & Li, X. (2013) · Nanoscale · doi:10.1039/c2nr33158f · Cited by 159
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
Buqué, A., Bloy, N., Aranda, F., Castoldi, F., Eggermont, A. M. M., Cremer, I., Fridman, W. H., Fucikova, J. P., Galon, J., Marabelle, A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008814 · Cited by 136
Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency
Duverger, A. E., Jones, J., May, J. E., Bibollet‐Ruche, F., Wagner, F. A., Cron, R. Q., & Kutsch, O. (2009) · Journal of Virology · doi:10.1128/jvi.02058-08 · Cited by 115
Organs-on-chips: research and commercial perspectives
Balijepalli, A., & Sivaramakrishan, V. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.009 · Cited by 89
Nielsen, C. H., Fassi, D. E., Hasselbalch, H. C., Bendtzen, K., & Hegedűs, L. D. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.1061 · Cited by 54
The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account
Hünig, T. (2016) · The FEBS Journal · doi:10.1111/febs.13754 · Cited by 47
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
Cabo, M., Offringa, R., Zitvogel, L., Kroemer, G., Muntasell, A., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1371896 · Cited by 40
Animal extrapolation in preclinical studies: An analysis of the tragic case of TGN1412
Lemoine, M. (2016) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2016.12.004 · Cited by 28
Jiang, H., & Chess, L. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.279 · Cited by 25
Xenograft models for the preclinical evaluation of new therapies in acute leukemia
Lee, E. M., Bachmann, P. S., & Lock, R. B. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190601113584 · Cited by 26
Regulating biopharmaceuticals under CDER versus CBER: an insider's perspective
Schwieterman, W. D. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.011 · Cited by 20
Sugarman, J., & Levine, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69881-4 · Cited by 19
Ohresser, M. C. P., Olive, D., Vanhove, B., & Watier, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69883-8 · Cited by 18
Risk Assessment in Extrapolation of Pharmacokinetics from Preclinical Data to Humans
Teitelbaum, Z., Lavé, T., Freijer, J. I., & Cohen, A. F. (2010) · Clinical Pharmacokinetics · doi:10.2165/11533760-000000000-00000 · Cited by 15
Novel Therapeutic Strategies for Solid Tumor Based on Body’s Intrinsic Antitumor Immune System
Duan, H. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489979 · Cited by 14
Maschmeyer, I., & Kakava, S. (2020) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2020_135 · Cited by 16
Biologics in the Pipeline: Large Molecules With High Hopes or Bigger Risks?
Zhou, H. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006297230 · Cited by 8
VandeBerg, J. L., Zola, S. M., Ely, J. J., & Kennedy, R. C. (2006) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2006.00193.x · Cited by 7
From pharmacology to immunopharmacology
Cohen, A. F. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02760.x · Cited by 6
Bhogal, N., & Combes, R. D. (2006) · Alternatives to Laboratory Animals · doi:10.1177/026119290603400301 · Cited by 5
Interplay between CD28 and PD-1 in T cell immunotherapy
Jafri, Z., Zhang, J., O’Meara, C. H., Joshua, A. M., Parish, C. R., & Khachigian, L. M. (2024) · Vascular Pharmacology · doi:10.1016/j.vph.2024.107461 · Cited by 5
Stirred Tank Reactors for Cell Culture Technology
Pangarkar, V. G. (2014) · Wiley eBooks · doi:10.1002/9781118807774.ch7b · Cited by 2
Estimation of Human Starting Dose for Phase I Clinical Programs
Buckley, L. A., Garhyan, P., Ponce, R. A., & Roberts, S. (2010) · Wiley eBooks · doi:10.1002/9780470613191.ch10 · Cited by 2
Antibodies in Phase I/II/III: Cancer Therapy
Deckert, P. M. (2007) · doi:10.1002/9783527619740.ch25
Promises and Challenges with Immunomodulatory Biologics
Ponce, R. A. (2014) · Wiley eBooks · doi:10.1002/9783527676965.ch8
Agyeman, A. A. (2016) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2016.04.00103
Al Zamil, M. (2018) · Open Access Journal of Translational Medicine & Research · doi:10.15406/oajtmr.2018.02.00051
Iversen, P. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-98164-2_4
In Vivo Models of Allogeneic Hematopoietic Stem Cell Transplantation
Welniak, L. A., & Murphy, W. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-478-0_44
Metadata
- Authors
- Hansen, S., & Leslie, R. G. Q.
- Affiliations
- University of Southern Denmark (DK)
- ORCID
- Hansen, Søren
- Venue
- Nature
- Published
- 2006-05-17
- Volume
- 441
- Issue
- 7091
- Pages
- 282-282
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2057244734
- Cited by
- 32
- References
- 1
- Citations by year
- 2024: 1 · 2020: 1 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 1 · 2014: 3 · 2012: 1
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- TGN1412, preclinical trials, adverse drug reactions, cytokine release syndrome, monoclonal antibodies, drug safety
- MeSH terms
- Animals, Antibodies, Monoclonal, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Macaca fascicularis, Macaca mulatta, Species Specificity, CD28 Antigens, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.